DUORESP

This brand name is authorized in Austria, Australia, Germany, Estonia, Spain, France, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, United Kingdom

Active ingredients

The drug DUORESP contains a combination of these active pharmaceutical ingredients (APIs):

1 Budesonide UNII Q3OKS62Q6X - BUDESONIDE

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. Read about Budesonide

2 Formoterol fumarate dihydrate UNII W34SHF8J2K - FORMOTEROL FUMARATE

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge. Read about Eformoterol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AK07	Formoterol and budesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11273H, 11301T, 12029D, 12093L
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 07767644, 10192897, 10311037, 10311043, 10311072, 10311089, 10813187, 10813193, 10813224, 10813230, 11031736, 11031771, 11054476, 11054482, 11054507, 11054513, 11112452, 11112469, 11135022, 11135045, 11135051, 11174654, 11174683, 11174708, 11174720, 11183848, 11183854, 11183883, 11183908, 11251691, 11251716, 11296245, 11296274, 11339776, 11339782, 11339799, 11339807, 11551565, 11732597, 12308950, 12308967, 12387211, 12387228, 12387234, 12387240, 12450702, 12607859, 12607865, 12740067, 13839684, 14178486, 14178492, 15561543, 15561566, 15561595, 15561603, 16003495, 16033361, 16033378, 16742637
Country: EE	Ravimiamet	Identifier(s): 1647086, 1647097, 1647109, 1647110, 1647121, 1647132
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114920001, 114920004
Country: FR	Base de données publique des médicaments	Identifier(s): 61331495, 67827270
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 252542, 252549, 368894, 368896, 374345, 374347, 376316, 376318, 381301, 381303
Country: IE	Health Products Regulatory Authority	Identifier(s): 53408, 53409, 53490, 53491
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7779, 7780
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1073288, 1073289, 1073290, 1073291, 1073292, 1073293
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 124176, 124184
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 19952, 19966
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100315522, 100315539
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63867001, W63868001